AU6012696A
(en)
|
1995-06-14 |
1997-01-15 |
Aberdeen University |
Prognostic and therapeutic system for cancer
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
USRE38490E1
(en)
|
1995-11-16 |
2004-04-06 |
Baylor College Of Medicine |
Method for identifying metastatic sequences
|
US5712097A
(en)
|
1996-01-19 |
1998-01-27 |
The Johns Hopkins University School Of Medicine |
Tumor suppressor gene, DPC4
|
JP3955636B2
(ja)
|
1996-07-15 |
2007-08-08 |
マヨ ファウンデーション フォーメディカル エデュケーション アンド リサーチ |
Hk2ポリペプチドを検出するための方法
|
US6479263B1
(en)
|
1996-11-14 |
2002-11-12 |
Baylor College Of Medicine |
Method for detection of micrometastatic prostate cancer
|
US6190857B1
(en)
|
1997-03-24 |
2001-02-20 |
Urocor, Inc. |
Diagnosis of disease state using MRNA profiles in peripheral leukocytes
|
AU8403098A
(en)
|
1997-07-15 |
1999-02-10 |
Deaconess Hospital |
Reagents and methods for diagnosis and prognosis of proliferative disor ders
|
US20020165143A1
(en)
|
1997-12-03 |
2002-11-07 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
FI980488A
(fi)
|
1998-03-04 |
1999-09-05 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
GB2339200B
(en)
|
1998-06-06 |
2001-09-12 |
Genostic Pharma Ltd |
Genostics
|
WO1999064627A2
(en)
|
1998-06-06 |
1999-12-16 |
Genostic Pharma Limited |
Probes used for genetic profiling
|
US6902892B1
(en)
|
1998-10-19 |
2005-06-07 |
Diadexus, Inc. |
Method of diagnosing, monitoring, staging, imaging and treating prostate cancer
|
CA2359816C
(en)
|
1999-01-06 |
2010-08-03 |
Genenews Inc. |
Method for the detection of gene transcripts in blood and uses thereof
|
CA2360073C
(en)
*
|
1999-01-28 |
2011-01-18 |
Gen-Probe Incorporated |
Probes and primers for detecting prostate specific antigen (psa) in a biological sample
|
US20030207808A1
(en)
|
1999-02-18 |
2003-11-06 |
Kinneret Savitzky |
Novel nucleic acid and amino acid sequences
|
FI990382A0
(fi)
*
|
1999-02-23 |
1999-02-23 |
Arctic Partners Oy Ab |
Uusi diagnostinen menetelmä
|
EP1961818A3
(en)
|
1999-04-09 |
2008-09-10 |
Chugai Seiyaku Kabushiki Kaisha |
Novel fetal genes
|
US6692916B2
(en)
|
1999-06-28 |
2004-02-17 |
Source Precision Medicine, Inc. |
Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
|
US6960439B2
(en)
|
1999-06-28 |
2005-11-01 |
Source Precision Medicine, Inc. |
Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
|
GB9926805D0
(en)
|
1999-11-13 |
2000-01-12 |
Zeneca Ltd |
Diagnostic methods
|
IL150676A0
(en)
*
|
2000-01-13 |
2003-02-12 |
Genentech Inc |
NOVEL STRa6 POLYPEPTIDES
|
US6448086B1
(en)
|
2000-01-18 |
2002-09-10 |
Diagnostic Systems Laboratories, Inc. |
Insulin-like growth factor system and cancer
|
US6566130B1
(en)
|
2000-01-28 |
2003-05-20 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Androgen-regulated gene expressed in prostate tissue
|
US7700359B2
(en)
|
2000-06-02 |
2010-04-20 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells
|
AU2002214576A1
(en)
|
2000-10-13 |
2002-04-22 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Genes related to development of refractory prostate cancer
|
AU2002216009A1
(en)
|
2000-11-03 |
2002-05-15 |
Michael Giesing |
Clinical and functional validation of targets from disseminated cancer cells
|
AU2002251844A1
(en)
|
2001-02-02 |
2002-10-03 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of colon cancer
|
CA2442820A1
(en)
|
2001-03-29 |
2002-10-10 |
Van Andel Institute |
Microarray gene expression profiling in clear cell renal cell carcinoma: prognosis and drug target identification
|
WO2002097438A1
(en)
|
2001-05-25 |
2002-12-05 |
Mount Sinai Hospital |
Method of detecting and monitoring prostate and ovarian cancers
|
JP2005503779A
(ja)
|
2001-06-10 |
2005-02-10 |
アイアールエム,エルエルシー |
致死性の高い癌の分子シグネチャー
|
WO2003009814A2
(en)
|
2001-07-25 |
2003-02-06 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
US20100297657A1
(en)
|
2001-08-02 |
2010-11-25 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
US7700293B2
(en)
|
2001-08-02 |
2010-04-20 |
The Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
JP5236856B2
(ja)
|
2001-11-09 |
2013-07-17 |
ライフ テクノロジーズ コーポレーション |
遺伝子発現プロファイルを用いる病気の同定、観測及び治療及び生物学的状態の同定
|
WO2003050243A2
(en)
|
2001-12-10 |
2003-06-19 |
Millennium Pharmaceuticals Inc. |
Novel genes encoding colon cancer antigens
|
US6949342B2
(en)
|
2001-12-21 |
2005-09-27 |
Whitehead Institute For Biomedical Research |
Prostate cancer diagnosis and outcome prediction by expression analysis
|
US20030215835A1
(en)
|
2002-01-15 |
2003-11-20 |
Zairen Sun |
Differentially-regulated prostate cancer genes
|
US20050112705A1
(en)
|
2002-03-14 |
2005-05-26 |
Laurent Bracco |
Variants of human kallikrein-2 and kallikrein-3 and uses thereof
|
AUPS187002A0
(en)
*
|
2002-04-22 |
2002-05-30 |
Queensland University Of Technology |
Condition-specific molecules and uses therefor
|
WO2004025258A2
(en)
|
2002-09-10 |
2004-03-25 |
Sydney Kimmel Cancer Center |
Gene segregation and biological sample classification methods
|
WO2004028346A2
(en)
|
2002-09-25 |
2004-04-08 |
Amersham Biosciences (Sv) Corp. |
Detection methods
|
WO2004053106A2
(en)
|
2002-12-05 |
2004-06-24 |
Regulome Corporation |
Profiled regulatory sites useful for gene control
|
AU2004209578A1
(en)
|
2003-02-07 |
2004-08-19 |
Diagnocure Inc. |
Method to detect prostate cancer in a sample
|
WO2004077942A2
(en)
|
2003-02-28 |
2004-09-16 |
Genpath Pharmaceuticals, Incorporated |
Inducible prostate cancer model
|
US20070059697A1
(en)
|
2003-04-15 |
2007-03-15 |
Avalon Pharmaceuticals, Inc |
Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods
|
US7659062B2
(en)
*
|
2003-06-03 |
2010-02-09 |
The Board of Trustee of the University of Arkansas System |
Gene expression profiling of uterine serous papillary carcinomas and ovarian serous papillary tumors
|
DK1641810T4
(da)
|
2003-06-24 |
2017-07-03 |
Genomic Health Inc |
Forudsigelse af sandsynligheden for cancerrecidiv
|
ES2905579T3
(es)
*
|
2003-07-10 |
2022-04-11 |
Genomic Health Inc |
Algoritmo del perfil de expresión y prueba para el pronóstico de la recaída del cáncer de mama
|
WO2005007830A2
(en)
|
2003-07-14 |
2005-01-27 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for diagnosis, staging and prognosis of prostate cancer
|
JP2007507204A
(ja)
|
2003-07-29 |
2007-03-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
サイクリン依存性キナーゼモデュレーションのバイオマーカー
|
EP1709152A4
(en)
|
2003-12-15 |
2007-11-07 |
Univ California |
MOLECULAR SIGNATURE OF PTEN TUMOR SUPPRESSOR
|
KR20070052694A
(ko)
|
2004-01-09 |
2007-05-22 |
더 리젠트스 오브 더 유니이버시티 오브 캘리포니아 |
유전자 발현을 위한 세포-유형-특이적 패턴
|
GB0400976D0
(en)
|
2004-01-16 |
2004-02-18 |
Univ Cambridge Tech |
Methods of diagnosis
|
WO2005076005A2
(en)
|
2004-01-30 |
2005-08-18 |
Medizinische Universität Wien |
A method for classifying a tumor cell sample based upon differential expression of at least two genes
|
JP2005211023A
(ja)
|
2004-01-30 |
2005-08-11 |
Hayashibara Biochem Lab Inc |
腎細胞癌の転移若しくは再発の可能性を予測する方法
|
WO2005083128A2
(en)
|
2004-02-25 |
2005-09-09 |
University Of South Florida |
Methods for predicting cancer outcome and gene signatures for use therein
|
US20070224596A1
(en)
|
2004-04-09 |
2007-09-27 |
Mariana Nacht |
Compositions and methods for the modifying hypoxia induced gene regulation
|
CA2848463A1
(en)
|
2004-04-09 |
2005-10-27 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
WO2005111619A1
(en)
|
2004-04-29 |
2005-11-24 |
Marc Ramael |
Method and kit for detecting components in a sample
|
CA2565450C
(en)
|
2004-05-07 |
2018-03-06 |
Gyorgy Petrovics |
Methods of diagnosing or treating prostate cancer using the erg gene, alone or in combination with other over or under expressed genes in prostate cancer
|
CN101023185A
(zh)
|
2004-05-27 |
2007-08-22 |
威特克斯医药股份有限公司 |
用于监测impdh通路抑制作用的生物学标记
|
CA2568732A1
(en)
|
2004-06-03 |
2005-12-15 |
Bayer Healthcare Ag |
Methods for predicting and monitoring response to cancer therapy
|
WO2006005043A2
(en)
|
2004-06-30 |
2006-01-12 |
Cemines, Inc. |
Compositions and methods for detecting protein interactions with target dna sequences
|
US7587279B2
(en)
|
2004-07-06 |
2009-09-08 |
Genomic Health |
Method for quantitative PCR data analysis system (QDAS)
|
WO2006028655A2
(en)
|
2004-08-13 |
2006-03-16 |
Millennium Pharmaceuticals, Inc. |
Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
|
US7572640B2
(en)
|
2004-09-28 |
2009-08-11 |
Singulex, Inc. |
Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties
|
AU2005304824B2
(en)
*
|
2004-11-05 |
2011-12-22 |
Genomic Health, Inc. |
Predicting response to chemotherapy using gene expression markers
|
AU2005308594A1
(en)
|
2004-11-24 |
2006-06-01 |
St George's Enterprises Limited |
Diagnosis of prostate cancer
|
EP1836313A4
(en)
|
2004-12-17 |
2010-06-30 |
Veridex Llc |
METHOD FOR ASSESSING PATIENTS WITH AKUTER MYELOIDER LEUKEMIA
|
US7943306B2
(en)
|
2005-01-12 |
2011-05-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene expression signature for prediction of human cancer progression
|
JP2008536480A
(ja)
|
2005-02-17 |
2008-09-11 |
ダナ−ファーバー キャンサー インスティテュート,インコーポレイテッド |
癌の同定、評価、予防、および治療用組成物、キット、および方法、ならびに癌の治療法
|
WO2006091776A2
(en)
*
|
2005-02-25 |
2006-08-31 |
The Brigham And Women's Hospital, Inc. |
Biomarkers for predicting prostate cancer progression
|
AU2006234897A1
(en)
*
|
2005-03-16 |
2006-10-19 |
Sidney Kimmel Cancer Center |
Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
|
WO2006105642A1
(en)
|
2005-04-05 |
2006-10-12 |
British Columbia Cancer Agency |
Biomarkers for the detection of lung cancer and uses thereof
|
CA2604852A1
(en)
|
2005-04-15 |
2006-10-26 |
Oncomethylome Sciences, S.A. |
Methylation markers for diagnosis and treatment of cancers
|
CA2608359A1
(en)
|
2005-05-13 |
2006-11-23 |
Duke University |
Gene expression signatures for oncogenic pathway deregulation
|
US20080275652A1
(en)
|
2005-05-13 |
2008-11-06 |
Universite Libre De Bruxelles |
Gene-based algorithmic cancer prognosis
|
US20060292610A1
(en)
|
2005-06-06 |
2006-12-28 |
Regents Of The University Of Michigan |
Prognostic meta signatures and uses thereof
|
EP1899486A4
(en)
|
2005-06-08 |
2009-07-22 |
Millennium Pharm Inc |
METHOD FOR IDENTIFYING, ASSESSING AND TREATING PATIENTS IN CANCER THERAPY
|
WO2006138275A2
(en)
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US20070099209A1
(en)
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
EP1934363B1
(en)
*
|
2005-09-12 |
2013-03-20 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
CA2629008A1
(en)
|
2005-11-08 |
2007-09-13 |
Euclid Diagnostics Llc |
Materials and methods for assaying for methylation of cpg islands associated with genes in the evaluation of cancer
|
CN101365806B
(zh)
|
2005-12-01 |
2016-11-16 |
医学预后研究所 |
用于鉴定治疗反应的生物标记的方法和装置及其预测疗效的用途
|
US8445198B2
(en)
|
2005-12-01 |
2013-05-21 |
Medical Prognosis Institute |
Methods, kits and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
|
EP2546359A1
(en)
|
2005-12-08 |
2013-01-16 |
Novartis AG |
Effects of inhibitors of FGFR3 on gene transcription
|
WO2007070621A2
(en)
|
2005-12-13 |
2007-06-21 |
Children's Medical Center Corporation |
Prognosis indicators for solid human tumors
|
WO2007075672A2
(en)
|
2005-12-23 |
2007-07-05 |
Lankenau Institute For Medical Research |
Prognostic cancer markers
|
NZ593224A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (fap) for colorectal cancer prognosis
|
ES2300176B1
(es)
*
|
2006-02-15 |
2009-05-01 |
Consejo Superior Investig. Cientificas |
Metodo para el diagnostico molecular de cancer de prostata, kit para implementar el metodo.
|
US20070218512A1
(en)
|
2006-02-28 |
2007-09-20 |
Alex Strongin |
Methods related to mmp26 status as a diagnostic and prognostic tool in cancer management
|
US7888019B2
(en)
|
2006-03-31 |
2011-02-15 |
Genomic Health, Inc. |
Genes involved estrogen metabolism
|
US7914988B1
(en)
|
2006-03-31 |
2011-03-29 |
Illumina, Inc. |
Gene expression profiles to predict relapse of prostate cancer
|
US20090098538A1
(en)
|
2006-03-31 |
2009-04-16 |
Glinsky Gennadi V |
Prognostic and diagnostic method for disease therapy
|
WO2007140352A2
(en)
|
2006-05-26 |
2007-12-06 |
Invitrogen Corporation |
Plasma membrane and secreted cancer biomarkers
|
WO2007149965A2
(en)
|
2006-06-22 |
2007-12-27 |
Wisconsin Alumni Research Foundation |
Stromal collagen in the diagnosis and characterization of breast cancer
|
WO2008036717A2
(en)
|
2006-09-19 |
2008-03-27 |
Emory University |
Use of soluble galectin-3 (gal-3) for cancer treatment
|
WO2008046510A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Healthcare Ag |
Fn1 as a biomarker, therapeutic and diagnostic target
|
WO2008048570A2
(en)
|
2006-10-16 |
2008-04-24 |
The Ohio State University Research Foundation |
Piwil2-related biomarkers and cell lines useful therewith
|
WO2008067065A2
(en)
*
|
2006-10-19 |
2008-06-05 |
Shiv Srivastava |
Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
|
WO2008058018A2
(en)
|
2006-11-02 |
2008-05-15 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
JP2010509598A
(ja)
|
2006-11-13 |
2010-03-25 |
ライフ テクノロジーズ コーポレーション |
前立腺癌バイオマーカーを検出するための方法およびキット
|
US20080131887A1
(en)
|
2006-11-30 |
2008-06-05 |
Stephan Dietrich A |
Genetic Analysis Systems and Methods
|
WO2008070160A2
(en)
|
2006-12-06 |
2008-06-12 |
Avalon Pharmaceuticals, Inc. |
Cancer-linked genes as biomarkers to monitor response to impdh inhibitors
|
AT504702A1
(de)
|
2006-12-22 |
2008-07-15 |
Arc Austrian Res Centers Gmbh |
Set von tumormarkern
|
JP2010517510A
(ja)
|
2007-01-09 |
2010-05-27 |
ブリストル−マイヤーズ スクイブ カンパニー |
前立腺細胞中のタンパク質チロシンキナーゼおよび/またはタンパク質チロシンキナーゼ経路と相互作用しかつ/またはそれを調節する化合物の活性を予測するためのポリヌクレオチドの同定
|
US20090047694A1
(en)
|
2007-08-17 |
2009-02-19 |
Shuber Anthony P |
Clinical Intervention Directed Diagnostic Methods
|
EP2140020A2
(en)
|
2007-03-15 |
2010-01-06 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
WO2008122447A2
(en)
|
2007-04-10 |
2008-10-16 |
Epigenomics Ag |
Dna methylation assay for the diagnosis or prognosis of medical conditions
|
AU2008251381B2
(en)
|
2007-05-11 |
2014-10-30 |
The Johns Hopkins University |
Biomarkers for melanoma
|
EP2068618A4
(en)
|
2007-05-21 |
2011-01-19 |
Dana Farber Cancer Inst Inc |
COMPOSITIONS AND METHODS OF DISCOVERING TUMOR GENES
|
US20110136123A1
(en)
|
2007-08-15 |
2011-06-09 |
Universite De Sherbrooke |
Alternative splicing gene variants in cancer
|
WO2009049966A2
(en)
|
2007-09-07 |
2009-04-23 |
Universite Libre De Bruxelles |
Methods and tools for prognosis of cancer in her2+ patients
|
WO2009051734A1
(en)
|
2007-10-17 |
2009-04-23 |
The General Hospital Corporation |
Microchip-based devices for capturing circulating tumor cells and methods of their use
|
GB0721605D0
(en)
|
2007-11-02 |
2007-12-12 |
Cancer Rec Tech Ltd |
Prostrate cancer susceptibility screening
|
US20090123439A1
(en)
|
2007-11-09 |
2009-05-14 |
The Jackson Laboratory |
Diagnostic and prognosis methods for cancer stem cells
|
WO2009070767A2
(en)
|
2007-11-28 |
2009-06-04 |
Whitehead Institute For Biomedical Research |
Systemic instigation systems to study tumor growth or metastasis
|
EP2065474A1
(en)
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic response to endocrine treatment
|
EP2215251A2
(en)
|
2007-11-30 |
2010-08-11 |
Siemens Healthcare Diagnostics GmbH |
Method for predicting therapy responsiveness in basal like tumors
|
WO2009089521A2
(en)
|
2008-01-10 |
2009-07-16 |
Nuvera Biosciences, Inc. |
Predictors for evaluating response to cancer therapy
|
WO2009105154A2
(en)
|
2008-02-19 |
2009-08-27 |
The Jackson Laboratory |
Diagnostic and prognostic methods for cancer
|
WO2009105640A1
(en)
|
2008-02-22 |
2009-08-27 |
Virginia Commonwealth University |
Signatures associated with rejection or recurrence of cancer
|
US8067178B2
(en)
|
2008-03-14 |
2011-11-29 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
RU2010143465A
(ru)
|
2008-03-26 |
2012-05-10 |
Теранос, Инк. (Us) |
Способ и система для прогнозирования клинических исходов
|
EP2105511A1
(en)
|
2008-03-28 |
2009-09-30 |
Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung e.V. |
Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
|
WO2009124251A1
(en)
|
2008-04-03 |
2009-10-08 |
Sloan-Kettering Institute For Cancer Research |
Gene signatures for the prognosis of cancer
|
CA2719172C
(en)
|
2008-04-10 |
2020-08-25 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Prostate cancer-specific alterations in erg8 gene expression and detection and treatment methods based on those alterations
|
US20110124003A1
(en)
|
2008-04-25 |
2011-05-26 |
Integrated Bioscience Solutions, Llc |
Cytological Methods for Detecting Cancer
|
US8093000B2
(en)
|
2008-05-09 |
2012-01-10 |
The Regents Of The University Of California |
Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
|
WO2009138392A1
(en)
|
2008-05-14 |
2009-11-19 |
ETH Zürich |
Method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment as well as biomarker assays determined therewith
|
CN102099491A
(zh)
|
2008-05-15 |
2011-06-15 |
北卡罗来纳-查佩尔山大学 |
调节血管生成的新靶标
|
WO2009140741A1
(en)
|
2008-05-23 |
2009-11-26 |
The University Of Queensland |
Agents and methods for diagnosing the presence or risk of prostate cancer
|
GB0809689D0
(en)
|
2008-05-28 |
2008-07-02 |
Cancer Res Inst Royal |
Markers for prostate cancee
|
CA2725978A1
(en)
|
2008-05-28 |
2009-12-03 |
Genomedx Biosciences, Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
US20090298082A1
(en)
*
|
2008-05-30 |
2009-12-03 |
Klee George G |
Biomarker panels for predicting prostate cancer outcomes
|
WO2009149166A2
(en)
|
2008-06-03 |
2009-12-10 |
Children's Hospital Medical Center |
Methods and compositions for the diagnosis and treatment of proliferative disorders
|
RU2011101378A
(ru)
|
2008-06-16 |
2012-07-27 |
Сайвидон Дайагностикс Гмбх (De) |
Алгоритмы предсказания исхода у пациентов с узловой формой рака молочной железы после химиотерапии
|
US20120009581A1
(en)
|
2008-07-08 |
2012-01-12 |
Bankaitis-Davis Danute M |
Gene Expression Profiling for Predicting the Survivability of Prostate Cancer Subjects
|
MX2011000451A
(es)
|
2008-07-16 |
2011-10-12 |
Dana Farber Cancer Inst Inc |
Distintivos y determinantes asociados con cancer de próstata y métodos para utilizarlos.
|
CA2731459A1
(en)
|
2008-07-21 |
2010-01-28 |
The Translational Genomics Research Institute |
Methods for diagnosis and prognosis of skin cancer
|
US9103819B2
(en)
|
2008-09-10 |
2015-08-11 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Peripheral zone tumor cells, methods for their preparation and use
|
PL2350316T3
(pl)
|
2008-10-20 |
2014-10-31 |
Valipharma |
Sposoby i zastosowania obejmujące aberracje genetyczne NAV3 i nieprawidłową ekspresję wielu genów
|
BRPI0914473A2
(pt)
|
2008-10-22 |
2019-09-24 |
Genentech Inc |
"célula-tronco de próstata e de câncer de próstata, métodos de isolamento de uma célula-tronco de próstata e de seleção de um paciente com câncer de próstata e métodos para inibir a proliferação de uma célula-tronco de próstata, para a prevenção de recidiva de câncer de próstata, para tratamento de câncer de próstata, para fornecimento de terapia adjuvante, para promover o crescimento ou reparação do tecido da próstata, para promover o crescimento da próstata, para fornecimento de próstata funcional e para selecionar um composto"
|
JP2012507300A
(ja)
|
2008-10-30 |
2012-03-29 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
Rnaパターンを評価する方法
|
WO2010056351A2
(en)
|
2008-11-14 |
2010-05-20 |
Stc.Unm |
Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia
|
WO2010056993A2
(en)
*
|
2008-11-14 |
2010-05-20 |
Emory University |
Prostate cancer biomarkers to predict recurrence and metastatic potential
|
GB0821787D0
(en)
|
2008-12-01 |
2009-01-07 |
Univ Ulster |
A genomic-based method of stratifying breast cancer patients
|
US20110236903A1
(en)
|
2008-12-04 |
2011-09-29 |
Mcclelland Michael |
Materials and methods for determining diagnosis and prognosis of prostate cancer
|
AU2010203825A1
(en)
|
2009-01-06 |
2011-07-21 |
Genomic Health, Inc. |
Gene expression profiling for the identification, monitoring, and treatment of prostate cancer
|
AU2010203542B2
(en)
|
2009-01-07 |
2017-02-23 |
Myriad Genetics, Inc |
Cancer biomarkers
|
AU2010204741B2
(en)
|
2009-01-14 |
2016-01-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Ratio based biomarkers and methods of use thereof
|
BRPI1007048A2
(pt)
|
2009-01-15 |
2016-02-10 |
Lab Corp America Holdings |
método e kit para correlacionar os níveis relativos da quantidade de pelo menos um de her-2 ou homodímeros de her-2 em uma amostra biológica de um indivíduo, e , método para prognosticar se um indivíduo com câncer e que é tratado com um agente que atua em her-2 é provável ter um evento significante.
|
EP2233590A1
(en)
|
2009-01-28 |
2010-09-29 |
AIT Austrian Institute of Technology GmbH |
Methylation assay
|
AU2010215838A1
(en)
|
2009-02-20 |
2010-08-26 |
John Wayne Cancer Institute |
B7-H3 antibody coupled bead assay for detection of circulating tumor cells
|
WO2010099577A1
(en)
|
2009-03-04 |
2010-09-10 |
The University Of Queensland |
Cancer biomarkers and uses therefor
|
US8639733B2
(en)
|
2009-03-16 |
2014-01-28 |
Apple Inc. |
Automatic identification of compatible applications and accessories
|
US8765383B2
(en)
|
2009-04-07 |
2014-07-01 |
Genomic Health, Inc. |
Methods of predicting cancer risk using gene expression in premalignant tissue
|
EP2419533A4
(en)
|
2009-04-16 |
2014-12-31 |
Nat Res Council Canada |
METHOD FOR DETECTING TUMOR CHARACTER STIKA AND MARKER SETS, TUMOR CLASSIFICATION AND MARKER SETS FOR CANCER
|
EP2241634A1
(en)
|
2009-04-16 |
2010-10-20 |
Université Libre de Bruxelles |
Diagnostic method and tools to predict the effiacy of targeted agents against IGF-1 pathway activation in cancer
|
WO2010127399A1
(en)
|
2009-05-06 |
2010-11-11 |
Walter And Eliza Hall Institute Of Medical Research |
Gene expression profiles and uses thereof
|
WO2010129965A1
(en)
|
2009-05-08 |
2010-11-11 |
The Regents Of The University Of California |
Cancer specific mitotic network
|
US20100303795A1
(en)
*
|
2009-05-27 |
2010-12-02 |
Soerensen Karina Dalsgaard |
Marker of prostate cancer
|
US10095829B2
(en)
|
2009-07-08 |
2018-10-09 |
Worldwide Innovative Network |
Computer implemented methods of treating lung cancer
|
WO2011039734A2
(en)
|
2009-10-02 |
2011-04-07 |
Enzo Medico |
Use of genes involved in anchorage independence for the optimization of diagnosis and treatment of human cancer
|
NZ599194A
(en)
|
2009-11-23 |
2014-07-25 |
Genomic Health Inc |
Methods to predict clinical outcome of cancer
|
NZ705645A
(en)
|
2010-01-11 |
2016-05-27 |
Genomic Health Inc |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
ES2537403T3
(es)
|
2010-07-27 |
2015-06-08 |
Genomic Health, Inc. |
Método para usar la expresión génica para determinar el pronóstico de cáncer de próstata
|
WO2014108896A1
(en)
|
2013-01-08 |
2014-07-17 |
Marpe Technologies Ltd. |
Device and method for body moles mapping and tracking
|